Q2 2025 Inspire Medical Systems Inc Earnings Call Transcript
Key Points
- Inspire Medical Systems Inc (INSP) reported a total revenue of $217.1 million for the quarter, marking an 11% increase from the previous year.
- The company experienced a 23% increase in revenue outside the US, indicating strong international growth.
- Early results from the Singapore clinical study showed a 20% reduction in surgical times with the Inspire V system, enhancing capacity at centers.
- The transition to Inspire V has led to a more than 20% increase in patient implants at US centers that have completed the transition.
- CMS proposed positive increases for Medicare reimbursement for the Inspire system, which could enhance future financial performance.
- The rollout of the Inspire V system faced delays due to challenges in training, contracting, and implementing SleepSync, impacting the transition timeline.
- The company had to adjust its full-year revenue guidance down to $900 million to $910 million from the previous $940 million to $955 million.
- There was a significant reduction in diluted net income per share guidance, from $2.20-$2.30 to $0.40-$0.50, reflecting revenue guidance changes and increased marketing costs.
- The adoption of the new CPT code for Medicare patients was delayed, affecting billing and revenue recognition until July.
- Operating expenses increased by 15% year-over-year, driven by sales organization expansion and increased corporate costs, impacting profitability.
Good afternoon. My name is [Dilem], and I'll be your conference operator today. At this time, I would like to welcome everyone to the Inspire Medical System second quarter 2025 conference call. (Operator Instructions) I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of investor relations at Inspire. You may begin the conference.
Thank you, [Dilem] and thank you all for participating in today's call. Joining me are Tim Herbert , Chairman and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the three months ended June 30, 2025. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including without limitation, those relating to our operations, financial results, and financial condition, investments in our business, full year 2025
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
